vs

Side-by-side financial comparison of ESAB Corp (ESAB) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

ESAB Corp is the larger business by last-quarter revenue ($727.8M vs $510.9M, roughly 1.4× Genius Sports Ltd). ESAB Corp runs the higher net margin — 7.5% vs -12.3%, a 19.9% gap on every dollar of revenue. ESAB Corp produced more free cash flow last quarter ($70.3M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 2.8%).

ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ESAB vs GENI — Head-to-Head

Bigger by revenue
ESAB
ESAB
1.4× larger
ESAB
$727.8M
$510.9M
GENI
Higher net margin
ESAB
ESAB
19.9% more per $
ESAB
7.5%
-12.3%
GENI
More free cash flow
ESAB
ESAB
$729.0K more FCF
ESAB
$70.3M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
2.8%
ESAB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ESAB
ESAB
GENI
GENI
Revenue
$727.8M
$510.9M
Net Profit
$54.8M
$-63.0M
Gross Margin
37.0%
25.2%
Operating Margin
14.6%
-11.5%
Net Margin
7.5%
-12.3%
Revenue YoY
8.5%
Net Profit YoY
2.1%
EPS (diluted)
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESAB
ESAB
GENI
GENI
Q4 25
$727.8M
$510.9M
Q3 25
$715.6M
$335.4M
Q2 25
$678.1M
$215.2M
Q1 25
$119.7M
Q4 24
$670.8M
$413.0M
Q3 24
$673.3M
$285.8M
Q2 24
$707.1M
$184.1M
Q1 24
$689.7M
$97.2M
Net Profit
ESAB
ESAB
GENI
GENI
Q4 25
$54.8M
$-63.0M
Q3 25
$66.9M
Q2 25
$67.4M
$-47.3M
Q1 25
$-25.5M
Q4 24
$53.7M
$-85.5M
Q3 24
$68.2M
$-47.1M
Q2 24
$82.9M
$-35.5M
Q1 24
$60.0M
$-25.2M
Gross Margin
ESAB
ESAB
GENI
GENI
Q4 25
37.0%
25.2%
Q3 25
37.2%
24.2%
Q2 25
37.6%
19.1%
Q1 25
10.7%
Q4 24
38.5%
16.7%
Q3 24
37.7%
20.5%
Q2 24
38.2%
18.6%
Q1 24
37.0%
9.8%
Operating Margin
ESAB
ESAB
GENI
GENI
Q4 25
14.6%
-11.5%
Q3 25
15.2%
-15.3%
Q2 25
16.2%
-21.0%
Q1 25
-20.3%
Q4 24
16.6%
-18.0%
Q3 24
15.7%
-13.9%
Q2 24
16.9%
-16.8%
Q1 24
16.0%
-23.7%
Net Margin
ESAB
ESAB
GENI
GENI
Q4 25
7.5%
-12.3%
Q3 25
9.3%
Q2 25
9.9%
-22.0%
Q1 25
-21.3%
Q4 24
8.0%
-20.7%
Q3 24
10.1%
-16.5%
Q2 24
11.7%
-19.3%
Q1 24
8.7%
-25.9%
EPS (diluted)
ESAB
ESAB
GENI
GENI
Q4 25
$0.90
Q3 25
$1.09
Q2 25
$1.10
Q1 25
Q4 24
$0.87
Q3 24
$1.11
Q2 24
$1.35
Q1 24
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESAB
ESAB
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$218.2M
$280.6M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$2.1B
$724.5M
Total Assets
$4.9B
$1.1B
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESAB
ESAB
GENI
GENI
Q4 25
$218.2M
$280.6M
Q3 25
$258.2M
$110.2M
Q2 25
$291.3M
$110.2M
Q1 25
$110.2M
Q4 24
$249.4M
$100.3M
Q3 24
$253.7M
$100.3M
Q2 24
$228.5M
$100.3M
Q1 24
$76.5M
$100.3M
Total Debt
ESAB
ESAB
GENI
GENI
Q4 25
$1.3B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Q1 24
$992.8M
Stockholders' Equity
ESAB
ESAB
GENI
GENI
Q4 25
$2.1B
$724.5M
Q3 25
$2.1B
$572.4M
Q2 25
$1.9B
$572.4M
Q1 25
$572.4M
Q4 24
$1.8B
$573.0M
Q3 24
$1.8B
$573.0M
Q2 24
$1.7B
$573.0M
Q1 24
$1.6B
$573.0M
Total Assets
ESAB
ESAB
GENI
GENI
Q4 25
$4.9B
$1.1B
Q3 25
$4.4B
$792.3M
Q2 25
$4.2B
$792.3M
Q1 25
$792.3M
Q4 24
$4.0B
$775.7M
Q3 24
$4.1B
$775.7M
Q2 24
$4.0B
$775.7M
Q1 24
$3.8B
$775.7M
Debt / Equity
ESAB
ESAB
GENI
GENI
Q4 25
0.63×
Q3 25
0.51×
Q2 25
0.55×
Q1 25
Q4 24
0.60×
Q3 24
0.59×
Q2 24
0.63×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESAB
ESAB
GENI
GENI
Operating Cash FlowLast quarter
$81.5M
$81.9M
Free Cash FlowOCF − Capex
$70.3M
$69.6M
FCF MarginFCF / Revenue
9.7%
13.6%
Capex IntensityCapex / Revenue
1.5%
2.4%
Cash ConversionOCF / Net Profit
1.49×
TTM Free Cash FlowTrailing 4 quarters
$238.0M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESAB
ESAB
GENI
GENI
Q4 25
$81.5M
$81.9M
Q3 25
$46.6M
$-4.8M
Q2 25
$35.4M
$-1.2M
Q1 25
$-14.6M
Q4 24
$126.9M
$14.9M
Q3 24
$101.0M
$-9.2M
Q2 24
$83.0M
Q1 24
$44.5M
Free Cash Flow
ESAB
ESAB
GENI
GENI
Q4 25
$70.3M
$69.6M
Q3 25
$37.4M
$-14.2M
Q2 25
$28.1M
$-5.8M
Q1 25
$-16.0M
Q4 24
$102.2M
$11.3M
Q3 24
$90.4M
$-11.6M
Q2 24
$74.0M
Q1 24
$37.1M
FCF Margin
ESAB
ESAB
GENI
GENI
Q4 25
9.7%
13.6%
Q3 25
5.2%
-4.2%
Q2 25
4.1%
-2.7%
Q1 25
-13.4%
Q4 24
15.2%
2.7%
Q3 24
13.4%
-4.1%
Q2 24
10.5%
Q1 24
5.4%
Capex Intensity
ESAB
ESAB
GENI
GENI
Q4 25
1.5%
2.4%
Q3 25
1.3%
2.8%
Q2 25
1.1%
2.1%
Q1 25
1.2%
Q4 24
3.7%
0.9%
Q3 24
1.6%
0.9%
Q2 24
1.3%
Q1 24
1.1%
Cash Conversion
ESAB
ESAB
GENI
GENI
Q4 25
1.49×
Q3 25
0.70×
Q2 25
0.53×
Q1 25
Q4 24
2.36×
Q3 24
1.48×
Q2 24
1.00×
Q1 24
0.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESAB
ESAB

Consumable Products$477.9M66%
Equipment Products$249.9M34%

GENI
GENI

Segment breakdown not available.

Related Comparisons